Small-molecule CB002 restores p53 pathway signaling and represses colorectal cancer cell growth

Colby Richardson1, Shengliang Zhang1,2, Liz J Hernandez Borrero1

  • 1a Penn State Hershey Cancer Institute , Hershey , PA , USA.

Insights

Researchers explored CB002 to restore the p53 tumor suppressor pathway, aiming to induce cancer cell death. This compound shows potential for targeted cancer therapy, even synergizing with chemotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • The p53 pathway is crucial for tumor suppression, frequently mutated or lost in human cancers.
  • Restoring p53 function offers a strategy for selective cancer cell death, sparing normal cells.
  • Tumor cells often evade p53 by mutation or MDM2 overexpression.

Purpose of the Study:

  • To evaluate the tumor cytotoxicity of compound CB002 and a related analog.
  • To investigate the potential of CB002 to restore the p53 pathway in cancer cells.
  • To determine if CB002 induces tumor cell apoptosis and growth arrest selectively.

Main Methods:

  • Screening of compounds from the Chembridge library, focusing on CB002 and a related analog.
  • Assessment of tumor cell cytotoxicity and effects on normal cells.
  • Analysis of p53 pathway signaling, including p53 and p73 activation, in cancer cell lines.

Main Results:

  • CB002 demonstrated tumor cytotoxicity without harming normal cells, suggesting p53 pathway restoration.
  • CB002 was shown to activate p53 pathway signaling, partly through p73, in p53-mutant cancer cells.
  • CB002 exhibited synergistic effects with chemotherapeutics CPT-11 and 5-FU, enhancing tumor cell death.

Conclusions:

  • Compound CB002 shows promise as a therapeutic agent for restoring p53 function in cancer.
  • CB002 induces tumor cell death and growth arrest, potentially via p53 and p73 pathway activation.
  • CB002 enhances the efficacy of conventional chemotherapy, offering a potential combination therapy strategy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K